Pharma Industry News & Biotech Industry News from Medical News Today

Pharma Industry / Biotech Industry News

Pharma Industry / Biotech Industry News

The latest Pharma Industry News & Biotech Industry News articles published daily. Includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Add this Pharma Industry rss news feed to your rss reader:

Latest News

Expansion Of USDA BioPreferred Program Presents Significant Opportunities For Industrial Biotechnology Companies

16 May 2008

The U.S. Department of Agriculture finalized three rules designating new categories of biobased products as eligible for BioPreferred purchasing by all federal agencies and contractors...
[read article]

Poniard To Present Clinical Data From Picoplatin Trials In Multiple Tumor Types At American Society Of Clinical Oncology 2008 Annual Meeting

16 May 2008

Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that the Company will present data from three clinical trials of picoplatin, in various tumor types and...
[read article]

Release Of Cytopia Abstract For CYT997 Oral Presentation At American Society Of Clinical Oncology

16 May 2008

Cytopia Limited (ASX: CYT) announced that the abstract for its upcoming oral presentation on CYT997 at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) will be accessible to the public via ASCO's website (http://www...
[read article]

Pharma Industry / Biotech Industry News Articles Archive - Page 1

16 May 2008

Schering-Plough Highlights PEGINTRON(TM) And Boceprevir Hepatitis C Data Presentations At Digestive Disease Week (DDW) Annual Meeting

Azor(TM) Reduces Blood Pressure In Difficult To Treat Special Populations

Terguride Receives FDA Orphan Drug Designation For The Treatment Of Pulmonary Arterial Hypertension

Cerenis Therapeutics Completes Phase I Clinical Trial Of CER-002 For Treatment Of Cardiovascular Disease

VIA Pharmaceuticals Completes Enrollment In Phase 2 Acute Coronary Syndrome (ACS) Trial

Novavax Completes Enrollment In Phase I/IIa Pandemic Influenza Vaccine Clinical Trial

IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program

Speakers Announced For The Pharma Marketing Summit 2008 In Zurich

10 VPs 85% Pharma Meet At Eyeforpharma's SFE USA 2008 Summit

BSI British Standards Publishes New Glossary To Help Promote The Safe And Efficient Commercialisation Of Regenerative Medicine Products In The UK

15 May 2008

Senate Revises Bill That Would Require Drug, Medical Device Makers To Publicly Report Payments, Gifts To Physicians

Senators Praise Growing Support For Transparency In Drug Industry Payments To Physicians, USA

Progen Resumes Phase 1 Development Of Anti Cancer Agent, PG 11047

Biopure Announces Publication Of Phase II Proof-of-Concept Coronary Trial

PRoFESS(R) Results Announced At XVII European Stroke Conference

New Data Shows 45 Percent Of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) And BENICAR HCT(R)

Neurobiological Technologies, Inc. Presents Dosing Rationale For Viprinex(TM) (ancrod) At The European Stroke Conference

Pharmasset Commences Dosing R7128 Cohorts 3 And 4 For The Treatment Of Chronic Hepatitis C

ISPE-PCC Awards Credential To Industry Professional

Medicines Australia Surprised By PBAC Measure

14 May 2008

FDA Approves Barr's Application To Sell Generic Version Of Oral Contraceptive Yasmin

Novel Treatment Offers Insomnia Sufferers Hope Of Quality Sleep

Zero Tolerance For Counterfeit Medicines

Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial Of Novel Bone Disease Therapy

TYKERB(R) (Lapatinib) To Be Investigated In Landmark Early Breast Cancer Trial

Medarex Announces Initiation Of Phase 2 Clinical Trials For The Treatment Of Ulcerative Colitis And Rheumatoid Arthritis

Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial

FDA Approves Taclonex Scalp(R) Once Daily Therapy For Treatment Of Moderate To Severe Scalp Psoriasis

13 May 2008

Canadian Drug Company Awarded Rwandan Contract To Provide Combination Antiretroviral

Cambridge Consultants To Unveil New Licensing Program For Dry Powder Inhaler "Gen-X" Development Tools At The Respiratory Drug Delivery Conference

Society Director Takes Up New Role With Bar Standards Board

Alseres Pharmaceuticals Announces 12 Month Interim Results From The Phase I/IIa Cethrin(R) Clinical Trial In Acute Spinal Cord Injury

12 May 2008

AARP Submits Testimony On DTC Advertising

Farm Bill Provisions Can Spur Production Of Advanced, Low-Carbon Biofuels

Drug Company Executives Respond To Concerns About Ads At House Panel Hearing

11 May 2008

New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective For Acute Pain From Common Foot Surgery

New Study Suggests Tapentadol IR For Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared To Oxycodone IR

09 May 2008

Biotech Career Fair Features Largest Employers In Life Sciences Industry

Hearing To Focus On Direct-To-Consumer Ads For Prescription Drugs

Regulatory Filing For FACTIVE Tablets Submitted In Europe

UK Architects RMJM To Design $90m Biotech Facility In Beijing

Overview Of Asenapine Data From Olympia Trial Program Presented At American Psychiatric Association Annual Meeting

New Lacosamide Data Provides Evidence For Long-Term Efficacy In Diabetic Neuropathic Pain

Vion Pharmaceuticals Announces Initiation Of Clinical Trial Of Cloretazine(R) (VNP40101M) In Combination With Cytarabine

Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor

Bayer And Regeneron Dose First Patient In Second Phase 3 Study For VEGF Trap-Eye In Wet Age-Related Macular Degeneration

08 May 2008

Senate Subcommittee Votes To Boost FDA Funding By 275 Million Dollars

Industry Distribution Of Journal Articles Ineffective, ASHP Tells FDA

Better Regulation Of Medicines Initiative - Third Report Launched, UK

Developers Finding Success Of Injectable Drugs Dependent On Numerous Factors -Analysis Trends And Prospects For Six Key Drug Classes

Preliminary Results From Phase 2 Genzyme Study Highlight Potential Of Novel Oral Compound For Gaucher Disease

New Analysis In Boys And Girls Shows The ADHD Patch, DAYTRANA(TM) (methylphenidate Transdermal System), Offered ADHD Symptom Control For 12 Months

OROS(R) Methylphenidate In Adults With ADHD: New Insights

Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms In Adolescents

NKTR-118 Shows Substantial Oral Bioavailability And Extended Half-Life In Phase 1 Clinical Data Presented At American Pain Society Meeting

Sigma Aldrich Joins Phase 2 Of The RNAi Consortium To Validate ShRNA Libraries

Trubion Announces Initiation Of Phase 2b Study Of TRU 015 For The Treatment Of Rheumatoid Arthritis

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]